Specifically, in the AD model group, both ZKSCAN3 gene and protein expression were significantly reduced, accompanied by enhanced lysosomal activity, reduced neuronal damage, and improved synaptic structure [98]. Here, ZKSCAN3 is linked to Alzheimer disease.